tradingkey.logo

Retractable Technologies Inc

RVP
0.656USD
+0.006+0.91%
收盘 02/09, 16:00美东报价延迟15分钟
16.61M总市值
亏损市盈率 TTM

Retractable Technologies Inc

0.656
+0.006+0.91%

关于 Retractable Technologies Inc 公司

Retractable Technologies, Inc. is engaged in the manufacturing and marketing of safety medical products (predominately syringes) for the healthcare industry. The Company is focused on the production of injection devices (syringes and needles). Such products are marketed under the VanishPoint, Patient Safe, and EasyPoint brands. The VanishPoint syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe syringes are designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint is a retractable needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint needle can also be used to aspirate fluids and for blood collection. Its products are distributed by various specialty and general line distributors.

Retractable Technologies Inc简介

公司代码RVP
公司名称Retractable Technologies Inc
上市日期May 04, 2001
CEOShaw (Thomas J)
员工数量221
证券类型Ordinary Share
年结日May 04
公司地址511 Lobo Lane
城市LITTLE ELM
上市交易所NASDAQ OMX – NASDAQ Basic Amex
国家United States of America
邮编75068-0009
电话19722941010
网址https://retractable.com/
公司代码RVP
上市日期May 04, 2001
CEOShaw (Thomas J)

Retractable Technologies Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Thomas J. Shaw
Mr. Thomas J. Shaw
Chairman of the Board, President, Chief Executive Officer, Founder
Chairman of the Board, President, Chief Executive Officer, Founder
16.33M
+13331.00%
Mr. Marco Laterza, CPA
Mr. Marco Laterza, CPA
Independent Director
Independent Director
85.00K
--
Mr. Darren E. Findley
Mr. Darren E. Findley
Independent Director
Independent Director
4.20K
--
Ms. Michele M. Larios, J.D.
Ms. Michele M. Larios, J.D.
Vice President, General Counsel, Secretary
Vice President, General Counsel, Secretary
--
--
Ms. Amy Mack
Ms. Amy Mack
Independent Director
Independent Director
--
--
Mr. Walter O. Bigby, Jr.
Mr. Walter O. Bigby, Jr.
Independent Director
Independent Director
--
--
Mr. John W. Fort, III
Mr. John W. Fort, III
Chief Financial Officer, Vice President, Treasurer, Director
Chief Financial Officer, Vice President, Treasurer, Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Thomas J. Shaw
Mr. Thomas J. Shaw
Chairman of the Board, President, Chief Executive Officer, Founder
Chairman of the Board, President, Chief Executive Officer, Founder
16.33M
+13331.00%
Mr. Marco Laterza, CPA
Mr. Marco Laterza, CPA
Independent Director
Independent Director
85.00K
--
Mr. Darren E. Findley
Mr. Darren E. Findley
Independent Director
Independent Director
4.20K
--
Ms. Michele M. Larios, J.D.
Ms. Michele M. Larios, J.D.
Vice President, General Counsel, Secretary
Vice President, General Counsel, Secretary
--
--
Ms. Amy Mack
Ms. Amy Mack
Independent Director
Independent Director
--
--
Mr. Walter O. Bigby, Jr.
Mr. Walter O. Bigby, Jr.
Independent Director
Independent Director
--
--

收入明细

单位: USD更新时间: 1月6日 周二
单位: USD更新时间: 1月6日 周二
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
业务USD
名称
营收
占比
Syringes
5.85M
57.98%
EasyPoint Needles
3.85M
38.21%
Blood Cllection Products
372.75K
3.70%
Other Products
11.46K
0.11%
地区USD
名称
营收
占比
United States
9.19M
91.09%
North and South America(excluding U.S)
549.80K
5.45%
Other International
348.35K
3.45%
业务
地区
业务USD
名称
营收
占比
Syringes
5.85M
57.98%
EasyPoint Needles
3.85M
38.21%
Blood Cllection Products
372.75K
3.70%
Other Products
11.46K
0.11%

股东统计

更新时间: 2月7日 周六
更新时间: 2月7日 周六
持股股东
股东类型
持股股东
持股股东
占比
Shaw (Thomas J)
54.55%
Larios Michele Mitchell
2.88%
The Vanguard Group, Inc.
2.25%
Renaissance Technologies LLC
1.43%
Eversept Partners, LP
1.21%
其他
37.68%
持股股东
持股股东
占比
Shaw (Thomas J)
54.55%
Larios Michele Mitchell
2.88%
The Vanguard Group, Inc.
2.25%
Renaissance Technologies LLC
1.43%
Eversept Partners, LP
1.21%
其他
37.68%
股东类型
持股股东
占比
Individual Investor
58.12%
Investment Advisor
4.12%
Hedge Fund
3.07%
Investment Advisor/Hedge Fund
0.92%
Venture Capital
0.05%
Research Firm
0.04%
其他
33.67%

机构持股

更新时间: 1月1日 周四
更新时间: 1月1日 周四
报告期
机构数
持股数
持股占比
持股变动
2025Q4
62
2.46M
8.20%
+132.22K
2025Q3
63
2.10M
7.00%
-941.15K
2025Q2
76
19.64M
65.62%
-749.70K
2025Q1
78
19.36M
64.67%
-761.97K
2024Q4
83
19.19M
64.11%
-1.01M
2024Q3
90
19.53M
65.24%
-827.36K
2024Q2
106
19.17M
64.04%
-1.44M
2024Q1
142
19.01M
63.51%
-2.11M
2023Q4
155
19.23M
64.23%
-1.87M
2023Q3
169
20.44M
68.26%
-2.39M
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Shaw (Thomas J)
16.33M
54.55%
+13.33K
+0.08%
Nov 14, 2025
Larios Michele Mitchell
861.00K
2.88%
--
--
Mar 10, 2025
The Vanguard Group, Inc.
672.81K
2.25%
-1.00K
-0.15%
Sep 30, 2025
Renaissance Technologies LLC
427.56K
1.43%
+79.16K
+22.72%
Sep 30, 2025
Eversept Partners, LP
363.31K
1.21%
+363.31K
--
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
241.12K
0.81%
-4.03K
-1.64%
Sep 30, 2025
Geode Capital Management, L.L.C.
128.11K
0.43%
--
--
Sep 30, 2025
Bridgeway Capital Management, LLC
88.54K
0.3%
-67.09K
-43.11%
Sep 30, 2025
Laterza (Marco)
85.00K
0.28%
--
--
Mar 10, 2025
Bigby (Walter O Jr)
80.00K
0.27%
--
--
Mar 10, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
占比0%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
KeyAI